483
Xiamen LP Pharmaceutical Co., Ltd.Xiamen LP Pharmaceutical Co., Ltd. – FDA 483, Mar 4, 2022
Record Details
Xiamen LP Pharmaceutical Co., Ltd, a drug manufacturer in Xiamen, China, received two observations during an FDA inspection. The firm was cited for failing to follow its written procedures for equipment calibration and for having a deficient supplier management program. These issues indicate a lack of adherence to established quality control practices for manufacturing and supplier oversight.
View Company Profile
ID · 595e588f-4cc5-402f-87ad-54fa29bbf051
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.